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Abstract: The dissociation constant of the circulating IgG antibodies is suggested to be proportional
to the partial concentrations of these antibodies in blood serum in equilibrium. This coefficient, called
serological number, is a dimensionless parameter and may be equal for all antibodies in a serum.
Based on the serological number, we derived the equilibrium equation of the humoral immune
system which allows estimating the number of different binding motifs in a serum. This equation also
allows estimating the number of binding motifs of posttranslational and conformational nature. The
feasibility of measuring the serological number via peptide arrays was demonstrated. Fifteen peptides
with unique binding motifs were incubated and stained with the blood serum of a healthy adult at
different dilutions. From these experiments, the serological number was determined. The serological
number may explain the pre-existing antibody response after vaccination.
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1. Introduction
The easy extraction of circulating serum antibodies from blood samples and their ability to
selectively bind to targets involved in immune defense make serum antibodies very attractive for
studying the immune system response. However, in many cases, the interpretation is complex and
requires considering the entire antibody repertoire as, for example, in the case of influenza-specific
antibody response after vaccination, which is shaped by pre-exposure history [1]. A straightforward
approach to performing serum-antibody profiling is serum sample incubation with random peptide
microarrays. Hereby, the reactivity of antibodies is measured using labeled secondary antibodies that
bind to the constant region of the subset of serum antibodies [2]. In the case of a limited number of
peptides (<1000), Greiff et al. have proposed to use multivariate regression analysis to predict the
peptide binding signals of the serum antibodies [3]. Although this method does not take into account
the information on amino acid position, the authors reported a successful prediction for up to 40%–50%
of the binding profiles for highly diverse random antibody mixtures which are not dominated by
a few antibodies. Legutki et al., claiming the limits of the state-of-the-art peptide technology, have
proposed to use a chip with the same 10 M random peptides to detect the so-called serological
immunosignatures—correlated patterns of the peptide binders specific for different infectious diseases
and cancers [4]. Sticking to the same sequences was determined by the very high costs of masks used
by the authors for lithographic peptide synthesis that makes it impossible, for example, to obtain the
binding motifs, i.e., invariant amino acids, without fabricating new peptides.
Due to the large progress in high throughput sequencing, a recombinant method has been used to
try and identify serum IgG binding targets [5,6]. Christiansen et al. used a bioinformatics approach
in order to identify binding peptide motifs of interest based on clustering and contrasting to control
samples from a phage display [7]. However, comparison of patient and control samples confirmed
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a major issue in phage display, namely, the selection of unspecific peptides and the necessity of their
validation, for instance, with peptide arrays. Weber et al. have combined the screening via phage
display with a substitutional analysis of the phage display hits via peptide arrays [8]. Using such
an approach, 42 unique binding motifs for IgG antibodies were identified in the serum of a healthy
donor. Such peptides include invariant combinations of amino acids and represent the epitopes of the
circulating antibodies.
Searching binding motifs of serum antibodies is believed to give insight into systemic reactions
of the humoral immune system because the invariant sequences may enable an easy identification
of the involved proteins by searching modern databases. On the other side, such characteristics as
the dissociation constant KD, or the fractional concentration N0, of antibodies seem to be less relevant
for the systemic analysis without knowing an immunogen. In addition, both parameters cannot
be obtained in a high throughput manner in comparison with the binding motifs. However, it is
interesting that both parameters have the same unit “mol/L” [9] and can build the dimensionless
serological number, or S-number:
S = KD/N0 (1)
Dimensionless combinations of parameters are frequently used to distinguish principal features
of complex phenomena as, for example, the Reynolds number for characterization of the fluid
flow. It is worth noticing that the S-number could be an intrinsic parameter of the immune system
and may represent an optimum between the number of circulating antibodies and their affinity
to the immunogens. The reason for this optimum may be the minimization of the high-affinity
antibody concentration to get more space for antibodies against other pathogens. In the case of
antibodies, one speaks about specific binding motifs, which can be obtained by so-called substitutional
analysis (Figure 1) [8]: all amino acids in a peptide MVPEFSGSFPMR are substituted in each
position against the 20 amino acids, while the rest of the sequence remains conserved, to define
the invariant amino acids—namely, the binding motif. The binding motifs can be clearly expressed
as X–A/I/P/V–P–E–F–X–G–A/S–X–P–X–X in Figure 1, or be heterogenic, allowing several invariant
amino acids in a certain position in the sequence (as indicated by a slash). In following these
considerations, we refer to the dissociation constant of an antibody KD and such binding motifs.
In this paper, we investigate the potential of the S-number as an additional parameter for studying the
immune response and demonstrate the possibility of its determination via peptide arrays.
Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  2 of 7 
 
confirmed a major issue in phage display, namely, the selection of unspecific peptides and the 
necessity of their validation, for instance, with peptide arrays. Weber et al. have combined the 
screening via phage display with a substitutional analysis of the phage display hits via peptide 
arrays [8]. Using such an approach, 42 unique binding motifs for IgG antibodies were identified in 
the serum of a healthy donor. Such peptides include invariant combinations of amino acids and 
represent the epitopes of the circulating antibodies. 
Searching binding motifs of serum antibodies is believed to give insight into systemic reactions 
of the humoral immune system because the invariant sequences may enable an easy identification of 
the involved proteins by searching modern databases. On the other side, such characteristics as the 
dissociation constant KD, or the fractional concentration N0, of antibodies seem to be less relevant for 
the systemic analysis without knowing an immunogen. In addition, both parameters cannot be 
obtained in a high throughput manner in comparison with the binding motifs. However, it is 
interesting that both parameters have the same unit “mol/L” [9] and can build the dimensionless 
serological number, or S-number: 
S = KD/N0 ( )
i i l  i i   r t  r  fr l   t  i ti i  ri i l f t r  
 co plex phenomena as, for example, the R ynolds number for characte ization of the luid flow. 
It is worth notici g that the S-number could be an intrinsic parameter of the immune system and 
may repres nt an optimum between the umber of ci culat ng antibodies and their affin ty to the 
immunogens. Th  reason for this optimum may be the minimizatio  of the high-affinity antibod  
concentrati  to get more space for antibodies against other pathogens. In the cas  of antibodies, one 
speaks about specific binding motifs, which can be obtained by so-called substitutional analysis 
(Figure 1) [8]: all amino acids in a pept e MVPEFSGSFP R are substituted in each posi ion against 
the 20 amino acids, while the rest of the sequence remains conserved, to define the in ariant ami o 
acids—namely, the binding motif. The binding motifs can be clearly expressed as X–A/I/P/V–P–E–F–
X–G S–X–P–X–X in Figure 1, or be heterogenic, allowing s v ral invariant am o acids in a ce t in 
pos ti n in the sequ nce (as indicated by a slash). In following these con ideratio s, we refer to th  
dissociation constant of an antibody KD and such binding motifs. In this paper, we investi ate he 
po ential of th  S-number as an additi nal paramet  for stu ying the immune e ponse and 
de onstrate the possibility f i s d terminat on via peptide arrays. 
 
Figure 1. Substitutional analysis of peptide MVPEFSGSFPMR reveals the binding motif X–A/I/P/V–
P–E–F–X–G–A/S–X–P–X–X [8]. The double spot array was used. Reproduced with permission, 
Copyright 2017, ELSEVIER. 
  
i 1. Substitutional analysis of peptide MVPEFSGSFPMR reveals the b nding motif
X A/I/P/V–P–E–F–X–G–A/S–X–P–X–X [8]. The double spot array was used. Reproduced with
permission, Copyright 2017, ELSEVIER.
Int. J. Mol. Sci. 2019, 20, 604 3 of 8
2. Results
2.1. Analytical Estimation of the S-Number of Different Binding Motifs
The sum of the S-numbers over all subset antibodies of a serum sample gives the equation of
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constant for all k. After the addition over the fractional concentrations of all antibodies and averaging
of the dissociation constants over Zbm, we obtain Formula (4), which states the relation between the





whereby Ntot is the total concentration of the antibodies in the serum. Applying in (4) the average
KD = 10−8 mol/L and Ntot = 10 g/L for the IgG antibodies, as well Zbm = 42 reported for the serum
used in this paper, S = 0.007 is obtained.
2.2. Dilution Measurements of the S-Number
Table 1 includes motifs that have been associated with antigens, like the polio vaccine or
Staphylococcus aureus motifs, which the immune system of the healthy donor has faced in the past,
as well as heterogeneous motifs with a large number of invariant amino acids. The heterogeneous
motifs cannot be unambiguously associated with a specific pathogen. The corresponding S-numbers,
measured according to (7), are presented in Table 1. The average value of the S-number over all
15 binding motifs is 0.0146 with a standard deviation of 0.0095.
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Table 1. Peptides corresponding to the binding motifs and their measured S-numbers.
N Amino AcidSequence Characteristics of the Motif S-number
Standard
Deviation in %
1 GGQVRSIHSGPT heterogeneous motif 0.00267 37
2 KEVPALTAVETGAT LXAXETX motif group, poliovirusmotif 0.00386 31
3 MVPEFSGSFPMR Staphylococcus aureus motif 0.00620 56
4 LIADLNAESTSR heterogeneous motif 0.00775 22
5 VLSSTAIKVDSV heterogeneous motif 0.00865 49
6 VMSVNASTTAAN heterogeneous motif 0.01183 41
7 QMKAWFPQTTYD KXXFPQXT motif 0.01219 48
8 LRPNAVQTDTLA heterogeneous motif 0.01302 39
9 SWVLTATETGSS LXAXETX motif group, poliovirus motif 0.01427 34
10 NPVEDYLDYSVI NPVEXXX motif 0.01490 60
11 ETKSDDMLLSNV heterogeneous motif 0.01537 31
12 AKIRMFLDTDYK heterogeneous motif 0.01841 58
13 VDTINLPQNTIQ heterogeneous motif 0.02059 49
14 TALDAVSTGFSW heterogeneous motif 0.02597 42
15 QHWPTNVDSVTV heterogeneous motif 0.04362 24
3. Discussion
Equation (4), which is based on the of the S-number approach, gives the value range of the
S-number from 0.007 for the 42 binding motifs to 0.049 for 300 binding motifs. It is interesting that the
S-numbers, which are measured independently according to (7), fall in this range. If we put the average
S-number, 0.0146, for the serum sample measured in this paper into (4), we will obtain 90 different
specific binders. We note that only 42 specific binder motifs were found by Weber et al. [8] for this
serum sample using phage display technology. This discrepancy may have two reasons. First, the
phage library did not include the rest of the linear specific binders. Secondly, the missing specific
binders may have a conformational or posttranslational nature, which cannot be registered either with
phage display or with linear peptide arrays. It is worth noticing that the derivation of (4) does not
include any assumptions about the epitope nature and, thus, can be used to estimate the number of
nonlinear epitopes that are very difficult to determine with any other methods.
In Table 1, we observe an increase of the S-number from 0.003 to 0.044, which still remains
in the estimated S-number interval, but cannot be explained even by relatively large measurement
errors. This deviation can be explained by differences in the IgG antibody affinities to the peptides
integrated in pathogenic proteins and the peptide spots synthesized on a solid support. For instance,
the 15th peptide exhibits an S-number of ~0.044, which is a factor ~3 higher than the averaged
S-number. This may mean that this binding motif embedded in a protein exhibits a KD smaller by
a factor ~3, i.e., has better affinity to the pathogen than the single peptide on a solid support.
The S-number can be explained on the cellular level when considering the mechanisms of the
long-term humoral memory (Figure 2).
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S = Zbm KD/∆N·α = βKDc/(∆N ∗ α) = Scβ/α, (5)
where α is the number of antibodies generated by a single plasma cell that has left the bone marrow, β
is the number of antibodies on a single B cell with the improved affinity, and Sc = KDc/∆N. The cellular
S-number Sc characterizes the generation of new plasma cells with a fractional concentration ∆N from
the B cells with an improved cellular dissociation constant KDc towards the antigen. The generated
plasma cells in the bone marrow will, in turn, build a fractional S-number Sk = KDc/∆N = KDk/N0k.
Here, the equations KDc = β·KDk and N0k = β·∆N were taken into account. Thus, we see that the
bone marrow transfers the serologic proportions from the B cells, with the improved affinity, to the
circulating antibodies. The reason for a larger fractional concentration of the plasmablasts and their
corresponding precursors—memory cells, with a smaller affinity to the antigen—may be due to the
fact that B cells with smaller affinities reenter additional rounds of mutative replication and, therefore,
they have a higher probability to be developed in larger amounts at the plasmablast stage.
The S-number approach allows developing a systemic view on the generation of serum antibodies
by vaccinations. As mentioned in the introduction, the influenza-specific antibody response after
vaccination is shaped by pre-exposure history [1,12–14]. Recent studies have shown that the vaccination
against influenza can boost up to 60% of pre-existing antibodies [15,16]. If numerous low-affinity
plasmablasts for a new viral antigen contact the survival niches, they eliminate 0.1% of the previously
stored plasma cells. According to the S-number, the number of low-affinity memory cells, and
correspondingly long-lived plasma cells in the bone marrow niches, is larger than the number of
plasma cells for high-affinity antigens. Thus, significantly more low-affinity pre-existing antibodies
than high-affinity pre-existing antibodies will be generated, as is observed after vaccination.
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4. Materials and Methods
4.1. Equation for Measurement of the S-Number in Array Format
Equation (2) describes the dependence of the dissociation constant between a protein and a ligand





where Isat is the maximum fluorescent signal at saturation, N the concentration of the analyte (antibody
in our case) in the solution, and KD is the equilibrium dissociation constant [17]. KD can be measured
in parallel for many molecules if one of the binding partners is arrayed in spots on a solid support and
the other carries a fluorescent label, and if its concentration, N, is known [18].
Using the definition of the S-number (1) and introducing the dilution factor γ = N/N0, Formula (6)





Obviously, the condition S = γ is reached at Iobs = Isat/2. This means that if the patient’s serum
will be constantly diluted, the dilution coefficient will be equal to the S-number at the signal Iobs
= Isat/2. Actually, the S-number can be measured by other Iobs and dilution values. The general
formula has the form S = α·k, by Iobs = Isat/(α + 1), where α is an arbitrary positive number and can be
defined from the fluorescent signal saturation curve. We chose Iobs = Isat/2, because this value refers to
IC50, known as half maximal inhibitory concentration and can be easily measured by the available
analytic techniques. Please note, to determine the S-number, it is not necessary to know either the
concentration of antibodies or coefficients that converts the fluorescent signal to concentration units.
Such a simple approach is especially useful for measuring S-numbers by studying a large number of
antibody interactions with combinatorically synthesized peptide arrays.
4.2. Methods to Measure the S-number
Blood serum of a healthy individual was used. Ethical clearance was obtained from the state
chamber of physicians of Baden-Wuerttemberg (reference number: F-2011-044 and F-2011-044#A1).
Identical peptide arrays were used for dilution experiments. The peptide content included binding
motifs for IgG serum antibodies of the healthy individual that were already determined by Weber
et al. [8]. Every peptide was represented by 10 to 40 spots. The serum was serially diluted, ranging
from 1:800 to 1:12.5, and incubated overnight. The serum was diluted in PBS-T containing 10% (v/v)
Rockland blocking buffer (Rockland Immunochemicals Inc., Pottstown, PA, USA). After the incubation,
the arrays were stained with the secondary antibody (goat) anti-human IgG (Fc γ) AF647 (Jackson
Immunoresearch, West Grove, PA, USA) at 1 µg/mL. Fluorescent signals were measured with an
InnoScan scanner (Innopsis, Carbonne, France). The collected fluorescent signals from the secondary
antibodies (Figure S1) and the dilution values were fit using Formula (6) to calculate the S-numbers
for each binding motif (Sections S2 and S3, Figures S2–S9, Supplementary Materials). The absolute
intensity for each pixel within a spot and the spot duplicate was averaged and background corrected.
Therefore, the average pixel intensity of a control area, not containing any peptide spots, was subtracted
from the calculated spot intensity. Fits with a coefficient of determination rs < 0.9 were discarded.
5. Conclusions
The S-number, as an additional parameter for the characterization of circulating antibodies, was
presented. It includes both the information about the antibody affinity and the fractional concentration.
Based on the assumption of a constant S-number for an antibody ensemble, the formula was
derived that combines the total concentration of antibodies, their average dissociation constant, and the
number of different binding motifs.
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The determination of the S-number was experimentally demonstrated. Therefore, the arrays with
the same peptide content representing the binding motifs were incubated with the serum samples of
a single human donor at different dilutions and stained with secondary anti-human IgG antibodies.
The signals obtained were approximated with the kinetic equation and, consequently, the antibody
S-numbers for each binding motif were determined.
The experimentally measured S-numbers revealed values of the same order of magnitude for all
motifs, and were approximated with the formula derived for the antibody ensemble with a constant
S-number. These results should not be considered as evidence for an equal S-number for all IgG
antibodies in human serum, and serve solely as an example of the measurement of the S-number
via peptide arrays. In addition, the nature of the S-number is discussed from the point of view of
B-cell ontogeny. The S-number may explain the generation of pre-existing antibodies after vaccination
against influenza.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/20/3/604/
s1.
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